- Home
- MRNA vs LW Comparison
MRNA vs LW Comparison
Compare MRNA & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | LW |
|---|---|---|
| Founded | 2010 | 1950 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 8.2B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRNA | LW |
|---|---|---|
| Price | $25.14 | $60.34 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 10 |
| Target Price | $33.91 | ★ $69.40 |
| AVG Volume (30 Days) | ★ 10.0M | 1.4M |
| Earning Date | 11-06-2025 | 12-19-2025 |
| Dividend Yield | N/A | ★ 2.45% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.08 |
| Revenue | $2,232,000,000.00 | ★ $6,456,500,000.00 |
| Revenue This Year | N/A | $4.12 |
| Revenue Next Year | $0.77 | N/A |
| P/E Ratio | ★ N/A | $29.10 |
| Revenue Growth | N/A | ★ 0.00 |
| 52 Week Low | $22.28 | $47.87 |
| 52 Week High | $48.92 | $83.98 |
Technical Indicators
Market Signals| Indicator | MRNA | LW |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 53.66 |
| Support Level | $23.92 | $58.53 |
| Resistance Level | $26.00 | $60.05 |
| Average True Range (ATR) | 1.19 | 1.38 |
| MACD | 0.09 | 0.37 |
| Stochastic Oscillator | 72.59 | 92.85 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About LW Lamb Weston Holdings Inc.
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.